2020
DOI: 10.1007/s12031-020-01616-6
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphism in the 3′-UTR of LIF but Not in the ATF6B Gene Associates with Schizophrenia Susceptibility: a Case-Control Study and In Silico Analyses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 36 publications
0
6
0
Order By: Relevance
“…The third selected SNP (rs7459185) is a downstream gene variant that is located on the near 3′UTR. Genetic variations in the 3′UTRs of genes can alter their expression by affecting miRNA binding and mRNA stability [ 42 , 44 , 45 ]. Although rs7459185 is outside of the 3′UTR sequence, a bioinformatics analysis showed a decrease in the HSPB1 mRNA expression levels in the presence of the rs7459185 CC genotype [ 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…The third selected SNP (rs7459185) is a downstream gene variant that is located on the near 3′UTR. Genetic variations in the 3′UTRs of genes can alter their expression by affecting miRNA binding and mRNA stability [ 42 , 44 , 45 ]. Although rs7459185 is outside of the 3′UTR sequence, a bioinformatics analysis showed a decrease in the HSPB1 mRNA expression levels in the presence of the rs7459185 CC genotype [ 46 ].…”
Section: Discussionmentioning
confidence: 99%
“…A previous study has indicated that the LIF gene impairs brain development in mice related to the mature and immature nervous system. 69 Butler and Moudi’s studies showed that genetic variations in the LIF gene may be related to neurodevelopmental disorders and related to increased susceptibility to schizophrenia and the degeneration of working memory function. 69 , 70 Thus, we suggest that the TBX1 and LIF genes may be candidates for ASD and deserve more focus and analysis.…”
Section: Discussionmentioning
confidence: 99%
“…Husemoen et al [52], Zhang et al [53], Hartz et al [54], Słomiń ki et al [55], Johansson et al [56], sPan et al [57], Lopez-Sanz et al [58], Grant, [59], Słomiń i et al [60], Galán et al sk [61], Jordan et al [62], Winkler et al [63], Yip et al [64], Crookshank et al [65], Lempainen et al [66], Qu and Polychronakos, [67], Morrison et al [68], Zhang et al [69], Gerlinger-Romero et al [70], Belanger et al [71], Dieter et al [72], Wanic et al [73], Ushijima Wanic et al [74], Guo et al [75], Davis et al [76], Elbarbary et al [77], Villasenor et al [78], Zhang et al [79], Lee et al [80], Zhi et al [81], Li Calzi et al [82], Sebastiani et al [83], Cherney et al [84], Doggrell, [85] and Yanagihara et al [86] found that FLG (filaggrin), FGF21, PEMT (phosphatidylethanolamine N-methyltransferase) KL (klotho), CEL (carboxyl ester lipase), FOSL2, STAT1, TCF7L2, TP53, EGFR (epidermal growth factor receptor), ETS1, KCNJ8, DEAF1, GCG (glucagon), IKZF4, OAS1, IRS1, ABCG2, FBXO32, PTBP1, BACH2, CNDP2, KLF11, MT1E, DPP4, SLC29A3, RGS16, MAS1, GCGR (glucagon receptor), HLA-C, VASP (vasodilator stimulated phosphoprotein), CCR2, PTGS2, GLP1R and JMJD6 are involved in the progression of T1DM. Vassilev et al [87], Qin et al [88], Ma et al [89], West et al [90], Hoffmann et al [91], Deary et al [92], Belangero et al [93], Jung et al [94], Tang et al [95], Goodier et al [96], Petyuk et al [97], Roux et al [98], Castrogiovanni et al [99], Suleiman et al [100], Haack et al [101], Kwiatkowski et al [102], Pinacho et al [103], Luo et al [104], He et al [105], Moudi et al [106], Thevenon et al [107], Li et al [108], Reitz et al [109], Jenkins and Escayg [110], Letronne et al [111], Ma et al [112], Chabbert et al [113], Abramsson et al [114], Aeby...…”
Section: Discussionmentioning
confidence: 99%